With this enhancement in the Chemotherapy Manager, a blue banner indicates when other users simultaneously access patient charts via the flowsheet or plan screen, enhancing collaboration. Synchronization between the flowsheet and scheduler ensures that during activity-based scheduling, the scheduler enters a read-only mode to prevent conflicting entries.
With this enhancement in the Chemotherapy Manager, users can create and manage off-plan administrations, allowing for the inclusion of necessary treatments not covered by the plan. This update facilitates the flexible administration of treatments as patient needs evolve.
With this enhancement in the Chemotherapy Manager, users can specify start dates, cycles, and days for ongoing treatments, using both the flowsheet and plan sections. This dual capability ensures accurate and up-to-date treatment timelines, facilitating precise therapy tracking and real-time adjustments.
This enhancement allows the user to replace current medications in a patient's treatment plan with biosimilars preferred by their insurance. It ensures the continuity of the treatment by preserving the schedule of the previously consumed drug for the newly replaced biosimilar, while historical treatment data is updated to reflect the change.
This enhancement in the Chemotherapy Manager System has been designed to facilitate the replacement of current medications in a patient's treatment plan with those preferred by their insurance, focusing on the transition from one brand to another, brand to generic drugs, or vice versa. This system ensures that when a drug is replaced due to insurance preferences, the historical data of drug consumption is preserved, reflecting the old medication on past treatment days and the new, replaced medication on future treatment days.
This enhancement in the Chemotherapy Manager has been designed to help healthcare providers manage and adjust chemotherapy treatment plans for their patients based on the changing preferences of insurance companies regarding medication. This enables the healthcare providers to easily update chemotherapy treatment plans with insurance-preferred drugs when insurance companies change their preferred drug lists.
With this enhancement in the Chemotherapy Manager, users can accurately specify drug dosages, for both NCCN and customized treatment protocols. This ensures that the appropriate and precise dosage is added to a patient's regimen, enhancing the accuracy of treatment plans.
With these enhancements in the Chemotherapy Manager, users benefit from an integrated suite of features for managing clinical trials, including detailed trial information, dynamic inclusion and exclusion criteria management, optimized treatment options, and flexible patient enrollment capabilities.
With these enhancements in the Chemotherapy Manager, users experience improved visibility of detailed adverse event information in the Flowsheet and Dashboard sections. This ensures that users can stay informed with all necessary details at a glance.
With this enhancement in the Chemotherapy Manager, users benefit from a streamlined process for managing adverse events. This includes adding, editing, and documenting detailed episodes for each adverse event helping strengthen the accuracy of patient care documentation.
Posted On: Dec 20, 2024
Posted On: Nov 27, 2024
Posted On: Nov 27, 2024
Posted On: Nov 27, 2024
Posted On: Nov 27, 2024
Posted On: Nov 27, 2024